₨ Official source-observed price
PKR 591.31
14's
PKR 42.24 / tablet
✓ Official DRAP price source observed · Source checked 2026-08-27
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 42.24/ tablet
Price position11% below medianvs like-for-like peer median
Peer comparators20current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Empagliflozin + Metformin
- Therapeutic area
- Endocrine & metabolic
- Drug class
- Antidiabetic medicines
- ATC
- A10BA
- Strength
- 12.5 mg + 850 mg
- Dosage form
- Tablet
- Pack
- 14's
- Registration no.
- 114698
- Price record verified
- 2026-09-08
- Latest DRAP source check
- 2026-08-27 02:56
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 591.31 | 2025-08-04 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Same generic
Other listed brands
Adrance-M 12.5 mg + 1000 mgAtco Laboratories Limited · PKR 1,659.57Adrance-M 5 mg + 500 mgAtco Laboratories Limited · PKR 1,333.22Adrance-M 5 mg + 850 mgAtco Laboratories Limited · PKR 356.00Adrance-M 5 mg + 1000 mgAtco Laboratories Limited · PKR 1,402.44Adrance-M 5 mg + 850 mgAtco Laboratories Limited · PKR 1,398.84Adrance-M 12.5 mg + 850 mgAtco Laboratories Limited · PKR 1,655.96Adrance-M 12.5 mg + 850 mgAtco Laboratories Limited · PKR 1,772.83Adrance-M 12.5 mg + 500 mgAtco Laboratories Limited · PKR 832.48
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 114698MedInfoBase. (2026). Erli 12.5 mg + 850 mg Tablet (14's), PHARMEVO (PVT) LTD. — registration and price record [Data set]. MedInfoBase. Retrieved September 22, 2026, from https://medinfobase.com/brand/erli-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd/ Data observed 22 September 2026. Source: DRAP PharmaPrice Index (recovered from snapshot #84). DRAP registration 114698.
MedInfoBase. Erli 12.5 mg + 850 mg Tablet (14's), PHARMEVO (PVT) LTD. — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 22]. Available from: https://medinfobase.com/brand/erli-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd/ Data observed 22 September 2026. Source: DRAP PharmaPrice Index (recovered from snapshot #84). DRAP registration 114698.
MedInfoBase (2026) Erli 12.5 mg + 850 mg Tablet (14's), PHARMEVO (PVT) LTD. — registration and price record. Available at: https://medinfobase.com/brand/erli-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd/ (Accessed: 22 September 2026).
"Erli 12.5 mg + 850 mg Tablet (14's), PHARMEVO (PVT) LTD. — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/erli-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd/. Accessed 22 Sep 2026.
MedInfoBase. 2026. "Erli 12.5 mg + 850 mg Tablet (14's), PHARMEVO (PVT) LTD. — registration and price record." Accessed September 22, 2026. https://medinfobase.com/brand/erli-12-5-mg-850-mg-114698-14s-pharmevo-pvt-ltd/.
Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.